66.76
[1]. Ashur-Fabian O, et, al. Tetrac Delayed the Onset of Ocular Melanoma in an Orthotopic Mouse Model. Front Endocrinol (Lausanne). 019 Jan 8; 9:775.
[]. Chin YT, et, al. Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ in Colorectal Cancers With Different K-RAS Status. Front Endocrinol (Lausanne). 019 Mar 1; 10:10.
[]. Davis PJ, et, al. Nongenomic Actions of Thyroid Hormone: the Integrin Component. Physiol Rev. 00 Jun 5.
[]. Rajabi M, et, al. Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer. Bioorg Med Chem Lett. 018 Apr 15;8(7):1-17.
[5]. Schmohl KA, et, al. Tetrac as an anti-angiogenic agent in cancer. Endocr Relat Cancer. 019 Jun 1; 6(6):R87-R0.
H00
P6-P70-P0-P05-P501
811